Literature DB >> 17332234

Calcium and vitamin D: what is known about the effects on growing bone.

Marie B Demay1, Yves Sabbagh, Thomas O Carpenter.   

Abstract

The objective of these investigations was to determine if the receptor-dependent effects of 1,25-dihydroxyvitamin D were essential for normal skeletal growth. Mice with targeted ablation of the vitamin D receptor were engineered, and the skeletal consequences of vitamin D receptor ablation were studied in the presence of normal and abnormal mineral ion homeostasis. Prevention of abnormal mineral ion homeostasis resulted in the development of a normal skeleton in the absence of a functional vitamin D receptor. The metabolic cause of rickets was found to be hypophosphatemia. The major receptor-dependent actions of 1,25-dihydroxyvitamin D on skeletal development are indirect and are a reflection of the role of this hormone on intestinal calcium absorption.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332234     DOI: 10.1542/peds.2006-2023F

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

1.  Forum on aging and skeletal health: summary of the proceedings of an ASBMR workshop.

Authors:  Sundeep Khosla; Teresita M Bellido; Marc K Drezner; Catherine M Gordon; Tamara B Harris; Douglas P Kiel; Barbara E Kream; Meryl S LeBoff; Jane B Lian; Charlotte A Peterson; Clifford J Rosen; John P Williams; Karen K Winer; Sherry S Sherman
Journal:  J Bone Miner Res       Date:  2011-09-13       Impact factor: 6.741

Review 2.  Bone metabolism in children and adolescents: main characteristics of the determinants of peak bone mass.

Authors:  Stefano Stagi; Loredana Cavalli; Chiara Iurato; Salvatore Seminara; Maria Luisa Brandi; Maurizio de Martino
Journal:  Clin Cases Miner Bone Metab       Date:  2013-09

Review 3.  The changing face of hypophosphatemic disorders in the FGF-23 era.

Authors:  Janet Y Lee; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2013-06

Review 4.  Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation.

Authors:  Murat Bastepe; Harald Jüppner
Journal:  Rev Endocr Metab Disord       Date:  2008-03-26       Impact factor: 6.514

Review 5.  Congenital Conditions of Hypophosphatemia in Children.

Authors:  Erik Allen Imel
Journal:  Calcif Tissue Int       Date:  2020-04-23       Impact factor: 4.333

6.  Hypovitaminosis D in obese and overweight schoolchildren.

Authors:  Filiz Mine Çizmecioğlu; Nilay Etiler; Uzay Görmüş; Onur Hamzaoğlu; Şükrü Hatun
Journal:  J Clin Res Pediatr Endocrinol       Date:  2008-11-05

7.  No relationship between vitamin D status and insulin resistance in a group of high school students.

Authors:  Dilek Erdönmez; Sükrü Hatun; Filiz Mine Çizmecioğlu; Alev Keser
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011

Review 8.  Burosumab for Pediatric X-Linked Hypophosphatemia.

Authors:  Erik A Imel
Journal:  Curr Osteoporos Rep       Date:  2021-05-10       Impact factor: 5.163

Review 9.  Kidney and phosphate metabolism.

Authors:  Nak-Won Choi
Journal:  Electrolyte Blood Press       Date:  2008-12-31

10.  Assessing bone health in children and adolescents.

Authors:  Michael A Levine
Journal:  Indian J Endocrinol Metab       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.